ha 1004 has been researched along with tretinoin in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 3 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Baldassare, JJ; Burns, D; Ceska, M; Fisher, GJ; Hammerberg, C; Henderson, PA; Voorhees, JJ; Zhang, QY | 1 |
| Hurme, M; Matikainen, S; Serkkola, E | 1 |
| Byers, DM; Cook, HW; Mandla, SG; Ridgway, ND | 1 |
3 other study(ies) available for ha 1004 and tretinoin
| Article | Year |
|---|---|
Retinoic acid and phorbol ester synergistically up-regulate IL-8 expression and specifically modulate protein kinase C-epsilon in human skin fibroblasts.
Topics: 1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine; Blotting, Western; Cells, Cultured; Cyclic AMP; Drug Synergism; Enzyme Activation; Fibroblasts; Gene Expression; Humans; In Vitro Techniques; Interleukin 1 Receptor Antagonist Protein; Interleukin-8; Isoquinolines; Phosphoproteins; Piperazines; Protein Kinase C; Protein Kinase Inhibitors; Proteins; RNA, Messenger; Sialoglycoproteins; Skin; Sulfonamides; Tetradecanoylphorbol Acetate; Tretinoin | 1992 |
Retinoic acid enhances IL-1 beta expression in myeloid leukemia cells and in human monocytes.
Topics: 1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine; Blotting, Northern; Bucladesine; Gene Expression; Humans; Interleukin-1; Isoquinolines; Leukemia, Myeloid; Lipopolysaccharides; Monocytes; Piperazines; Protein Kinase Inhibitors; RNA, Messenger; Sulfonamides; Tetradecanoylphorbol Acetate; Transcription, Genetic; Tretinoin; Tumor Cells, Cultured | 1991 |
Differential alterations of ethanolamine and choline phosphoglyceride metabolism by clofibrate and retinoic acid in human fibroblasts are not mediated by phorbol ester-sensitive protein kinase C.
Topics: 1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine; Carcinogens; Clofibrate; Enzyme Inhibitors; Ethanolamine; Ethanolamines; Fibroblasts; Humans; Hypolipidemic Agents; Isoquinolines; Phosphatidylcholines; Phospholipids; Protein Kinase C; Skin; Staurosporine; Sulfonamides; Tetradecanoylphorbol Acetate; Time Factors; Tretinoin | 1996 |